JOA - 2026-11-05 - Journal Article
The Impact of Tourniquet Duration on Postoperative Opioid Use and Recovery After Total Knee Arthroplasty.
Weinblatt AI, Lan R, Oettl FC, Ondeck NT, Gonzalez AG, Lyman S, Chalmers BP, Gonzalez Della Valle A
Topics
Key Takeaway
Full-duration tourniquet use in TKA was associated with 78% higher odds of manipulation under anesthesia (OR 1.64) and 4.1 additional hours to PT clearance compared to no tourniquet, while partial tourniquet use reduced 90-day opioid consumption by 90 MME.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This single-center retrospective study categorized 17,850 primary unilateral TKA patients by tourniquet inflation ratio (none, partial <0.6, until-closure 0.6–1.0, full ≥1.0) and assessed postoperative opioid use, PT clearance, MUA rate, and KOOS JR at 6 weeks. Tourniquet-until-closure and full-duration strategies increased inpatient MME (+10 and +14 respectively), delayed PT clearance (+2.7 and +4.1 hours), and elevated MUA odds (OR 1.78 and 1.64) versus no tourniquet. Partial tourniquet reduced 90-day opioid consumption by 90 MME without increasing PT delay or MUA risk, and KOOS JR did not differ across groups.
Key Limitation
The retrospective single-center design cannot establish causality, and unmeasured confounders such as case complexity, surgeon preference, and anesthetic technique may systematically differ across tourniquet groups.
Original Abstract
INTRODUCTION
Tourniquet use during total knee arthroplasty (TKA) remains common, but its effects on postoperative pain, opioid use, and stiffness are unclear. We evaluated whether tourniquet duration was associated with pain- and stiffness-related outcomes after primary TKA.
METHODS
We performed a retrospective study of 17,850 adults undergoing primary unilateral TKA at a single center from March 2016 to June 2023. Tourniquet use was categorized by inflation time relative to operative time as no tourniquet (n = 1,243), partial tourniquet (less than 0.6; n = 2,914), tourniquet-until-arthrotomy-closure (≥ 0.6 to less than 1; n = 10,003), or full-duration tourniquet (≥ 1; n = 3,690). The primary outcome was postoperative pain assessed by postoperative inpatient and cumulative 90-day morphine milligram equivalents (MME). The secondary outcomes were hours to clear physical therapy (PT), manipulation under anesthesia (MUA) within 120 days, and patient-reported Knee injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR) at six weeks. Multivariable regressions adjusted for covariates. The no-tourniquet group served as the reference.
RESULTS
Partial-tourniquet use was associated with lower 90-day opioid consumption (-90 MME; 95% confidence interval (CI) -150 to -30; P = 0.003). Tourniquet-until-closure and full-duration tourniquet were associated with higher inpatient opioid consumption (+10 MMEs; 95% CI, 2 to 17; P = 0.015; and +14 MMEs; 95% CI, 6 to 22; P = 0.001), longer time to PT clearance (+2.7 hours, 95% CI, 1.0 to 4.5; P = 0.002; and +4.1 hours, 95% CI, 2.2 to 5.9; P < 0.001), and higher adjusted odds (OR) of MUA (OR 1.78, 95% CI, 1.14 to 2.79; P = 0.012; and OR 1.64, 95% CI, 1.02 to 2.64; P = 0.040). Partial-tourniquet use was not associated with increased time to clear PT or increased odds of MUA. The KOOS JR scores did not differ significantly across strategies.
CONCLUSIONS
Tourniquet use during TKA showed duration-dependent associations with postoperative outcomes. Partial-tourniquet use may represent a balanced strategy, associated with lower cumulative 90-day opioid consumption without the delayed PT clearance or increased MUA risk observed with longer-duration tourniquet strategies.